Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Gains from Investment Securities (2019 - 2024)

Historic Gains from Investment Securities for INVO Fertility (IVF) over the last 9 years, with Q2 2024 value amounting to $50000.0.

  • INVO Fertility's Gains from Investment Securities fell 5876.46% to $50000.0 in Q2 2024 from the same period last year, while for Dec 2024 it was -$511663.0, marking a year-over-year change of. This contributed to the annual value of -$511663.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that INVO Fertility reported Gains from Investment Securities of $50000.0 as of Q2 2024, which was down 5876.46% from -$561663.0 recorded in Q1 2024.
  • In the past 5 years, INVO Fertility's Gains from Investment Securities ranged from a high of $1.5 million in Q2 2022 and a low of -$561663.0 during Q1 2024
  • In the last 5 years, INVO Fertility's Gains from Investment Securities had a median value of $121255.0 in 2023 and averaged $622990.0.
  • In the last 5 years, INVO Fertility's Gains from Investment Securities skyrocketed by 16158914.47% in 2022 and then crashed by 13976.26% in 2024.
  • Quarter analysis of 5 years shows INVO Fertility's Gains from Investment Securities stood at $56509.0 in 2020, then crashed by 95.76% to $2395.0 in 2021, then soared by 61678.91% to $1.5 million in 2022, then plummeted by 92.39% to $112628.0 in 2023, then plummeted by 55.61% to $50000.0 in 2024.
  • Its last three reported values are $50000.0 in Q2 2024, -$561663.0 for Q1 2024, and $112628.0 during Q3 2023.